Takeshi Yokoyama

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Venues

Journal of medicinal chemistry

FEBS letters

The FEBS journal

IUCrJ

University of Toyama

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Toyama Jun 01 2011

Japan

Assistant professor :: Faculty of Pharmaceutical Sciences

Publications

Takeshi Yokoyama, Yuki Takayama, Mineyuki Mizuguchi, Yuko Nabeshima, Katsuhiro Kusaka
SIRT5 mutants reveal the role of conserved asparagine and glutamine residues in the NAD + -binding pocket. FEBS letters (2024)
Mineyuki Mizuguchi, Yusuke Nakagawa, Takeshi Yokoyama, Takuya Okada, Kanako Fujii, Kanoko Takahashi, Nguyen Ngoc Thanh Luan, Yuko Nabeshima, Kayoko Kanamitsu, Shinsaku Nakagawa, Shiori Yamakawa, Mitsuharu Ueda, Yukio Ando, Naoki Toyooka
Development of Benziodarone Analogues with Enhanced Potency for Selective Binding to Transthyretin in Human Plasma. Journal of medicinal chemistry (2024)
Mineyuki Mizuguchi, Yusuke Nakagawa, Takeshi Yokoyama, Takuya Okada, Kanako Fujii, Kanoko Takahashi, Nguyen Ngoc Thanh Luan, Yuko Nabeshima, Kayoko Kanamitsu, Shinsaku Nakagawa, Shiori Yamakawa, Mitsuharu Ueda, Yukio Ando, Naoki Toyooka
Development of Benziodarone Analogues with Enhanced Potency for Selective Binding to Transthyretin in Human Plasma. Journal of medicinal chemistry (2024)
Mineyuki Mizuguchi, Yusuke Nakagawa, Takeshi Yokoyama, Takuya Okada, Kanako Fujii, Kanoko Takahashi, Nguyen Ngoc Thanh Luan, Yuko Nabeshima, Kayoko Kanamitsu, Shinsaku Nakagawa, Shiori Yamakawa, Mitsuharu Ueda, Yukio Ando, Naoki Toyooka
Development of Benziodarone Analogues with Enhanced Potency for Selective Binding to Transthyretin in Human Plasma. Journal of medicinal chemistry (2024)
Tomonao Inobe, Runa Sakaguchi, Takayuki Obita, Atushi Mukaiyama, Seiichi Koike, Takeshi Yokoyama, Mineyuki Mizuguchi, Shuji Akiyama
Structural insights into rapamycin-induced oligomerization of a FRB-FKBP fusion protein. FEBS letters (2024)
Takeshi Yokoyama, Katsuhiro Kusaka, Mineyuki Mizuguchi, Yuko Nabeshima, Satoru Fujiwara
Resveratrol Derivatives Inhibit Transthyretin Fibrillization: Structural Insights into the Interactions between Resveratrol Derivatives and Transthyretin. Journal of medicinal chemistry (2023)
Takeshi Yokoyama, Mineyuki Mizuguchi, Yuko Nabeshima, Yusuke Nakagawa, Takuya Okada, Naoki Toyooka, Katsuhiro Kusaka
Rafoxanide, a Salicylanilide Anthelmintic, Interacts with Human Plasma Protein Transthyretin. The FEBS journal (2023)
Takeshi Yokoyama, Katsuhiro Kusaka
Characterization of the Molecular Interactions between Resveratrol Derivatives and Death-associated Protein Kinase 1. The FEBS journal (2023)
Takeshi Yokoyama, Katsuhiro Kusaka
Characterization of the molecular interactions between resveratrol derivatives and death-associated protein kinase 1. The FEBS journal (2023)
Mineyuki Mizuguchi, Takeshi Yokoyama, Takahito Otani, Shiori Kuribara, Yuko Nabeshima, Takayuki Obita, Masato Hirata, Keiichi Kawano
Structural and mutational analyses of decarboxylated osteocalcin provide insight into its adiponectin-inducing activity. FEBS letters (2023)
Takeshi Yokoyama, Shiho Fujii, Andreas Ostermann, Tobias E Schrader, Yuko Nabeshima, Mineyuki Mizuguchi
Neutron crystallographic analysis of the nucleotide-binding domain of Hsp72 in complex with ADP. IUCrJ 9 (Pt 5) (2022)
Mineyuki Mizuguchi, Yusuke Nakagawa, Kishin Inui, Wakana Katayama, Yurika Sawai, Ayaka Shimane, Ryota Kitakami, Takuya Okada, Yuko Nabeshima, Takeshi Yokoyama, Kayoko Kanamitsu, Shinsaku Nakagawa, Naoki Toyooka
Chlorinated Naringenin Analogues as Potential Inhibitors of Transthyretin Amyloidogenesis. Journal of medicinal chemistry (2022)
Takeshi Yokoyama, Mirai Kashihara, Mineyuki Mizuguchi
Repositioning of the Anthelmintic Drugs Bithionol and Triclabendazole as Transthyretin Amyloidogenesis Inhibitors. Journal of medicinal chemistry 64 (19) (2021)
Takeshi Yokoyama, Ryoya Suzuki, Mineyuki Mizuguchi
Crystal structure of death-associated protein kinase 1 in complex with the dietary compound resveratrol. IUCrJ 8 (Pt 1) (2021)
Katsuhiro Kusaka, Takeshi Yokoyama, Taro Yamada, Naomine Yano, Ichiro Tanaka, Mineyuki Mizuguchi
Neutron diffraction experiment with the Y116S variant of transthyretin using iBIX at J-PARC: application of a new integration method. Acta crystallographica. Section D, Structural biology 76 (Pt 11) (2020)
Takeshi Yokoyama, Mineyuki Mizuguchi
Transthyretin Amyloidogenesis Inhibitors: From Discovery to Current Developments. Journal of medicinal chemistry 63 (23) (2020)
Takeshi Yokoyama, Peter Wijaya, Yuto Kosaka, Mineyuki Mizuguchi
Structural and thermodynamic analyses of interactions between death-associated protein kinase 1 and anthraquinones. Acta crystallographica. Section D, Structural biology 76 (Pt 5) (2020)
Takeshi Yokoyama, Mineyuki Mizuguchi
Crown Ethers as Transthyretin Amyloidogenesis Inhibitors. Journal of medicinal chemistry 62 (4) (2019)

Takeshi Yokoyama.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Takeshi Yokoyama